期刊文献+

HIV/HCV混合感染CD4^+细胞计数与HCV病毒载量的相关性研究 被引量:5

Correlation between CD4^+ count and plasma HCV viral load in HIV/HCV co- infections
下载PDF
导出
摘要 目的:通过分析HIV/HCV混合感染的CD4+细胞计数与HCV病毒载量(HCVVL)的相关性,探讨HIV感染时细胞免疫状况对HCV病毒水平的影响。方法:同时测定CD4+细胞计数与HCV-RNA定量,研究两者的相关性。结果:CD4+细胞计数与HCV-RNA定量不相关(r=-0.120,P=0.479)。结论:HIV/HCV混合感染时,细胞免疫状态对HCV病毒载量没有明显影响。 Objective To analyze the correlation between CD4^+ count and HCV viral load in HIV/HCV co-infections, in order to investigate the influence of the cellular immunity on the HCV viral load in HIV infections. Methods To detect the CD4^+ count and HCV-RNA level in 37 patients with HIV/HCV co-infections at the same time, and then study the association of them from Aug, 1999 to Sep, 2004. Results There was no correlation between CD4^+ count and HCV-RNA level( r = -0. 120, P=0.479). Conclusion When HIV/HCV co-infected, the cellular immunity had no influence on the HCV viral load.
出处 《实用医学杂志》 CAS 2005年第19期2133-2134,共2页 The Journal of Practical Medicine
基金 广东省医学科学技术研究基金资助项目(项目编号:A2001583)
  • 相关文献

参考文献10

  • 1Bica I,McGovern B,Dhar R,et al.Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.Clin Infect Dis,2001,32(3):492-497.
  • 2Thomas DL,Astemborski J,Rai RM,et al.The natural history of hepatitis C virus infection:host,viral,and environmental factors.JAMA,2000,284(4):450-456.
  • 3丙型肝炎防治指南[J].中华流行病学杂志,2004,25(5):369-375. 被引量:65
  • 4Kenny-Walsh E.Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.Irish Hepatology Research Group.N Engl J Med,1999,340(16):1228-1233.
  • 5Fattovich G,Giustina G,Degos F,et al.Morbidity and mortality in compensated cirrhosis type C:a retrospective follow-up study of 384 patients.Gastroenterology,1997,112(2):463-472.
  • 6Greub G,Ledergerber B,Battegay M,et al.Clinical progression,survival,and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection:the Swiss HIV Cohort Study.Lancet,2000,356(9244):1800-1805.
  • 7Sulkowski MS,Moore RD,Mehta SH,et al.Hepatitis C and progression of HIV disease.JAMA,2002,288(2):199-206.
  • 8Dorrucci M,Pezzotti P,Phillips AN,et al.Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS,Italian Seroconversion Study.J Infect Dis,1995,172(6):1503-1508.
  • 9Neumann AU,Lam NP,Dahari H,et al.Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.Science,1998,282(53866):103-107.
  • 10Laskus T,Radkowski M,Piasek A,et al.Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1:evidence of active replication in monocytes/macrophages and lymphocytes.J Infect Dis,2000,181(2):442-448.

二级参考文献15

  • 1Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol, 2003, 38(suppl 1)∶s1014-s1118.
  • 2Booth JCL, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut, 2001, 49(suppl 1)∶ s1-s21.
  • 3Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. Gut, 2002, 51∶864-869.
  • 4Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review. Hepatology,2002,36(5 suppl 1)∶s135-s144.
  • 5Di Ciommo V, Russo P, Rava L, et al. Interferon alpha in the treatment of chronic hepatitis C in children: a meta-analysis. J Viral Hepat, 2003, 10∶210-214.
  • 6Fabrizi F, Dulai G, Dixit V, et al. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther, 2003, 18∶1071-1081.
  • 7Kjaergard LL, Krogsgaard K, Gluud C. Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials. BMJ, 2001, 323∶1151-1155.
  • 8National Institute of Health Consensus Development Conference Panel Statement. Management of hepatitis C. Hepatology, 2002, 36(5 suppl 1)∶s3-s20.
  • 9Papatheodoridis GV, Papadimitropoulos VC, Hadziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis. Aliment Pharmacol Ther, 2001, 15∶689-698.
  • 10Poynard T, McHutchison J, Davis GL, et al. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology, 2000, 32∶1131-1137.

共引文献64

同被引文献33

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2张永宏,陈新月,蒋岩,肖瑶,刘震,龙小山,吴昊.HIV/HCV重叠感染患者肝脏功能进展原因分析[J].临床肝胆病杂志,2004,20(5):269-271. 被引量:7
  • 3杨忠礼,彭红,夏志刚,王丽.HIV和HCV重迭感染者病毒载量间及与T淋巴细胞计数的相关性研究[J].中国艾滋病性病,2005,11(2):84-87. 被引量:4
  • 4王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:631
  • 5Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology, 1999, 30: 1054- 1058.
  • 6Marin6-Barjoan E, Saint-Paul MC, Pradier C, et al. Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/ hepatitis C virus coinfected patients. AIDS, 2004, 18: 2163-2170.
  • 7Puoti M, Bruno R, Soriano V, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS, 2004, 18:2285-2293.
  • 8Al-Mohri H, Murphy T, Lu Y, et al. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker. J Acquir Immune Defic Syndr, 2007, 44: 463-469.
  • 9Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med, 1992, 327: 1779-1784.
  • 10Sato T, Sekine H, Kakuda H, et al. HIV infection of megakaryocytic cell lines. Leuk Lymphoma, 2000, 36: 397-404.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部